It is with great sadness we announce the death of Professor Eivind Berge.
He died in early February from aggressive prostate cancer. He was a major contributor to stroke science and to evidence-based medicine.
He ran large clinical trials of his own, but also had major roles in key international stroke trials.
He was a research leader, a mentor to junior researchers, and a good friend to many in the stroke community.
His wise judgement and broad experience were highly valued by colleagues around the world.
His work with trials, systematic reviews and guidelines have improved the treatment and prognosis of stroke patients. Eivind had a unique combination of wisdom, kindness and determination and our community has lost a wonderful friend and colleague.
Our thoughts are with Eivinds’s family.